Insider Transactions in Q4 2025 at Vera Therapeutics, Inc. (VERA)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 15
2025
|
William D. Turner Chief Regulatory Officer |
SELL
Open market or private sale
|
Direct |
10,000
-30.77%
|
$500,000
$50.08 P/Share
|
|
Dec 15
2025
|
William D. Turner Chief Regulatory Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+23.53%
|
$150,000
$15.53 P/Share
|
|
Dec 11
2025
|
Patrick G Enright |
BUY
Open market or private purchase
|
Direct |
5,882
+50.0%
|
$247,044
$42.5 P/Share
|
|
Dec 08
2025
|
William D. Turner Chief Regulatory Officer |
SELL
Open market or private sale
|
Direct |
10,000
-30.77%
|
$450,000
$45.31 P/Share
|
|
Dec 08
2025
|
William D. Turner Chief Regulatory Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+23.53%
|
$150,000
$15.53 P/Share
|
|
Dec 03
2025
|
William D. Turner Chief Regulatory Officer |
SELL
Open market or private sale
|
Direct |
10,000
-30.77%
|
$400,000
$40.0 P/Share
|
|
Dec 03
2025
|
William D. Turner Chief Regulatory Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+23.53%
|
$150,000
$15.53 P/Share
|
|
Nov 21
2025
|
Jason S Carter Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,864
-7.29%
|
$104,328
$27.82 P/Share
|
|
Nov 13
2025
|
Joseph R Young SVP, FINANCE, CHIEF ACCT OFFCR |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+14.74%
|
$30,000
$3.94 P/Share
|
|
Nov 11
2025
|
Joseph R Young SVP, FINANCE, CHIEF ACCT OFFCR |
SELL
Open market or private sale
|
Direct |
15,000
-23.87%
|
$435,000
$29.06 P/Share
|